# Evaluation of the Efficacy and Safety of Using Platelet-rich Fibrin (PRF)-Based Lipobolus for the Immediate Reconstruction of Defects After Breast-conserving Resection for Breast Cancer (Minimally Invasive Primary Immediate Grafting)

> **NCT07658170** · NA · RECRUITING · sponsor: **The Leningrad Regional Clinical Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Breast Cancer
- Lipofilling
- Fat Graft
- Platelet Rich Plasma

## Interventions

- **PROCEDURE:** Lipobolus (Autologous Fat + Platelet-Rich Fibrin+Calcium chloride)

## Key facts

- **NCT ID:** NCT07658170
- **Lead sponsor:** The Leningrad Regional Clinical Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-13
- **Primary completion:** 2026-01-13
- **Final completion:** 2028-06-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658170, "Evaluation of the Efficacy and Safety of Using Platelet-rich Fibrin (PRF)-Based Lipobolus for the Immediate Reconstruction of Defects After Breast-conserving Resection for Breast Cancer (Minimally Invasive Primary Immediate Grafting)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07658170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*